Comparison of therapeutic outcomes of sorafenib and lenvatinib as primary treatments for hepatocellular carcinoma with a focus on molecular-targeted agent sequential therapy: A propensity score-matched analysis期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Comparison of therapeutic outcomes of sorafenib and lenvatinib as primary treatments for hepatocellular carcinoma with a focus on molecular-targeted agent sequential therapy: A propensity score-matched analysis

Authors:	Tetsu Tomonari Yasushi Sato Joji Tani Akira Hirose Chikara Ogawa Akihiro Morishita Hironori Tanaka Takahiro Tanaka Tatsuya Taniguchi Koichi Okamoto Masahiro Sogabe Hiroshi Miyamoto Naoki Muguruma Kazushige Uchida Tsutomu Masaki Tetsuji Takayama

Affiliation:	1. Department of Gastroenterology and Oncology, Institute of Biomedical Sciences, Tokushima University Graduate School of Medicine, Tokushima, Tokushima, Japan;2. Department of Community Medicine for Gastroenterology and Oncology, Institute of Biomedical Sciences, Tokushima University Graduate School of Medicine, Tokushima, Tokushima, Japan;3. Department of Gastroenterology and Neurology, Kagawa University Graduate School of Medicine, Miki-cho, Kagawa, Japan;4. Department of Gastroenterology and Hepatology, Kochi University Graduate School of Medicine, Kochi, Kochi, Japan;5. Department of Gastroenterology and Hepatology, Takamatsu Red Cross Hospital, Takamatsu, Kagawa, Japan

Abstract:

Keywords:	hepatocellular carcinoma lenvatinib molecular-targeted agent prognosis propensity score matching sorafenib